Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hetrombopag vs rhTPO for platelet engraftment after allogeneic HSCT
ChiCTR2200057764Phase 4Recruiting
- Sponsor
- Xinqiao Hospital
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of hetrombopag in Thrombocytopenia (2 arms), sponsored by Xinqiao Hospital. Primary endpoint: Mean time to successful platelet reconstitution with hetrombopag after transplantation. Started Mar 2022; status: recruiting.
02
Drugs
hetrombopag
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on ChiCTR2200057764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057764.